Zimbabwe has rejected a significant American health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential data.
This rejection came to light after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesman has since explained that the United States was demanding access to health data for research and commercial gain while was unwilling to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further dialogue to reach a deal acceptable to all parties so the country's vital HIV programme can proceed.
Broader Context
This rejection comes after a comparable case in Kenya, where a court blocked a similar deal with the US after concerns were filed about the safety of citizens' medical information.
Since returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
As per statements, 16 African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," Mangwana explained.
"In essence, our country would supply the basic resources for medical research without any certainty that the resulting innovations would be available to our population should a new pandemic arise."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining frameworks already established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This mechanism is intended to ensure that when a country contributes its data, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We are open to further dialogue with our US partners on how subsequent co-operation might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts expressed it understood the official position, but urged that negotiations must proceed since much of the nation's HIV programmes were funded by international support.
"If technical issues exist, including those relating to information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group added.
The situation highlights the complex challenges between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.